On the public citation graph

Prescription omega-3 fatty acid products: considerations for patients with diabetes mellitus

0 signed · 95 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/14651858.cd003205.pub2openalex-snapshot

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus

inferredcites →https://doi.org/10.1002/cpdd.150openalex-snapshot

Effects of icosapent ethyl (Eicosapentaenoic acid ethyl ester) on pharmacokinetic parameters of rosiglitazone in healthy subjects

inferredcites →https://doi.org/10.1002/jsfa.5994openalex-snapshot

Quality analysis of commercial fish oil preparations

inferredcites →https://doi.org/10.1002/jsfa.6816openalex-snapshot

A comparison of actual versus stated label amounts of EPA and DHA in commercial omega‐3 dietary supplements in the United States

inferredcites →https://doi.org/10.1007/s11883-011-0210-3openalex-snapshot

Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis

inferredcites →https://doi.org/10.1007/s40119-014-0032-9openalex-snapshot

Retrospective Case Series of Patients with Diabetes or Prediabetes Who Were Switched from Omega-3-Acid Ethyl Esters to Icosapent Ethyl

inferredcites →https://doi.org/10.1007/s40256-012-0002-3openalex-snapshot

Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies

inferredcites →https://doi.org/10.1007/s40261-014-0194-1openalex-snapshot

Phase 1 Study of the Effect of Icosapent Ethyl on Warfarin Pharmacokinetic and Anticoagulation Parameters

inferredcites →https://doi.org/10.1007/s40261-014-0252-8openalex-snapshot

Effect of Concomitant Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on the Pharmacokinetics of Atorvastatin

inferredcites →https://doi.org/10.1007/s40268-014-0053-9openalex-snapshot

Effect of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Omeprazole Plasma Pharmacokinetics in Healthy Adults

inferredcites →https://doi.org/10.1016/j.ahj.2008.08.027openalex-snapshot

Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: A phase 3, randomized, controlled study

inferredcites →https://doi.org/10.1016/j.amjcard.2006.11.020openalex-snapshot

Safety Considerations with Omega-3 Fatty Acid Therapy

inferredcites →https://doi.org/10.1016/j.amjcard.2006.11.021openalex-snapshot

Expert Opinion: Omega-3 Fatty Acids and Bleeding—Cause for Concern?

inferredcites →https://doi.org/10.1016/j.amjcard.2008.10.025openalex-snapshot

Efficacy and Safety of ABT-335 (Fenofibric Acid) in Combination With Atorvastatin in Patients With Mixed Dyslipidemia

inferredcites →https://doi.org/10.1016/j.amjcard.2011.04.015openalex-snapshot

Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)

inferredcites →https://doi.org/10.1016/j.amjcard.2012.05.031openalex-snapshot

Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)

inferredcites →https://doi.org/10.1016/j.atherosclerosis.2008.06.003openalex-snapshot

Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)

inferredcites →https://doi.org/10.1016/j.atherosclerosis.2008.09.027openalex-snapshot

Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: A phase 3 study

inferredcites →https://doi.org/10.1016/j.atherosclerosis.2009.03.029openalex-snapshot

Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS)

inferredcites →https://doi.org/10.1016/j.clinthera.2007.07.018openalex-snapshot

Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study

inferredcites →https://doi.org/10.1016/j.clinthera.2013.07.420openalex-snapshot

A Highly Bioavailable Omega-3 Free Fatty Acid Formulation Improves the Cardiovascular Risk Profile in High-Risk, Statin-Treated Patients With Residual Hypertriglyceridemia (the ESPRIT Trial)

inferredcites →https://doi.org/10.1016/j.clnu.2011.08.013openalex-snapshot

Omega-3 polyunsaturated fatty acid and insulin sensitivity: A meta-analysis of randomized controlled trials

inferredcites →https://doi.org/10.1016/j.jacl.2011.10.018openalex-snapshot

Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: A review

inferredcites →https://doi.org/10.1016/j.jacl.2012.04.002openalex-snapshot

Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels

inferredcites →https://doi.org/10.1016/j.jacl.2013.10.003openalex-snapshot

Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial

inferredcites →https://doi.org/10.1016/j.jacl.2013.12.005openalex-snapshot

An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report

inferredcites →https://doi.org/10.1016/j.jacl.2014.07.007openalex-snapshot

National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary

inferredcites →https://doi.org/10.1016/j.jacl.2015.03.086openalex-snapshot

Pharmacokinetic and Triglyceride-lowering Pharmacodynamic Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) Across Clinical Studies†

inferredcites →https://doi.org/10.1016/j.jnutbio.2011.03.004openalex-snapshot

Modulation of blood cell gene expression by DHA supplementation in hypertriglyceridemic men

inferredcites →https://doi.org/10.1016/j.jvs.2013.07.030openalex-snapshot

n-3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors

inferredcites →https://doi.org/10.1016/j.jvs.2015.08.004openalex-snapshot

Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

inferredcites →https://doi.org/10.1016/j.plefa.2013.01.001openalex-snapshot

Distinct regulation of plasma LDL cholesterol by eicosapentaenoic acid and docosahexaenoic acid in high fat diet-fed hamsters: Participation of cholesterol ester transfer protein and LDL receptor

inferredcites →https://doi.org/10.1016/s0002-8703(03)00367-3openalex-snapshot

Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS)

inferredcites →https://doi.org/10.1016/s0002-9149(98)00731-0openalex-snapshot

Efficacy and safety of an extended-release niacin (niaspan): a long-term study

inferredcites →https://doi.org/10.1016/s0021-9150(98)00301-3openalex-snapshot

Correlation of serum triglyceride and its reduction by ω-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins

inferredcites →https://doi.org/10.1016/s0140-6736(07)60527-3openalex-snapshot

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

inferredcites →https://doi.org/10.1017/s000711451300425xopenalex-snapshot

n-3 Fatty acids affect haemostasis but do not increase the risk of bleeding: clinical observations and mechanistic insights

inferredcites →https://doi.org/10.1038/srep07928openalex-snapshot

Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA

inferredcites →https://doi.org/10.1056/nejm199807233390404openalex-snapshot

Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction

inferredcites →https://doi.org/10.1056/nejmoa1203859openalex-snapshot

n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia

inferredcites →https://doi.org/10.1056/nejmoa1205409openalex-snapshot

n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors

inferredcites →https://doi.org/10.1056/nejmoa1410489openalex-snapshot

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

inferredcites →https://doi.org/10.1056/nejmoa1500858openalex-snapshot

Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

inferredcites →https://doi.org/10.1056/nejmoa1501031openalex-snapshot

Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

inferredcites →https://doi.org/10.1056/nejmp1315559openalex-snapshot

Hazards of Hindsight — Monitoring the Safety of Nutritional Supplements

inferredcites →https://doi.org/10.1080/07315724.2008.10719743openalex-snapshot

Differences between Dietary Supplement and Prescription Drug Omega-3 Fatty Acid Formulations: A Legislative and Regulatory Perspective

inferredcites →https://doi.org/10.1089/met.2011.0004openalex-snapshot

Long Chain Omega-3 Dietary Supplements: A Review of the National Library of Medicine Herbal Supplement Database

inferredcites →https://doi.org/10.1089/met.2014.0137openalex-snapshot

Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester): Effects Upon High-Sensitivity C-Reactive Protein and Lipid Parameters in Patients With Metabolic Syndrome

inferredcites →https://doi.org/10.1093/eurheartj/ehs431openalex-snapshot

Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction

inferredcites →https://doi.org/10.1096/fasebj.28.1_supplement.1035.6openalex-snapshot

Relationship between baseline triglyceride concentration and triglyceride reduction with 4 g/d long‐chain omega‐3 acid ethyl esters (1035.6)

inferredcites →https://doi.org/10.1097/00043798-199710000-00011openalex-snapshot

Safety and efficacy of Omacor in severe hypertriglyceridemia

inferredcites →https://doi.org/10.1111/j.1365-2621.2003.tb07042.xopenalex-snapshot

Omega‐3 Fatty Acids and Total Polychlorinated Biphenyls in 26 Dietary Supplements

inferredcites →https://doi.org/10.1161/atvbaha.107.151092openalex-snapshot

Metabolic Syndrome Pandemic

inferredcites →https://doi.org/10.1161/atvbaha.113.302926openalex-snapshot

Effects of Fenofibric Acid on Carotid Intima-Media Thickness in Patients With Mixed Dyslipidemia on Atorvastatin Therapy

inferredcites →https://doi.org/10.1161/circulationaha.109.192644openalex-snapshot

Harmonizing the Metabolic Syndrome

inferredcites →https://doi.org/10.1177/0091270006289849openalex-snapshot

Study of the Pharmacokinetic Interaction Between Simvastatin and Prescription Omega‐3‐Acid Ethyl Esters

inferredcites →https://doi.org/10.1177/174182679700400511openalex-snapshot

Safety and Efficacy of Omacor in Severe Hypertriglyceridemia

inferredcites →https://doi.org/10.1186/1475-2840-12-100openalex-snapshot

Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study

inferredcites →https://doi.org/10.1186/1475-2840-13-26openalex-snapshot

Residual macrovascular risk in 2013: what have we learned?

inferredcites →https://doi.org/10.1210/jc.2011-3213openalex-snapshot

Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline

inferredcites →https://doi.org/10.12816/0004790openalex-snapshot

Standards of Medical Care in Diabetes 2014

inferredcites →https://doi.org/10.1345/aph.1q110openalex-snapshot

Incidence of Hospitalized Rhabdomyolysis with Statin and Fibrate Use in an Insured US Population

inferredcites →https://doi.org/10.1517/14656560802233827openalex-snapshot

Effect of omega-3-acid ethyl esters on steady-state plasma pharmacokinetics of atorvastatin in healthy adults

inferredcites →https://doi.org/10.1517/14656560802532640openalex-snapshot

Effect of omega-3-acid ethyl esters on the steady-state plasma pharmacokinetics of rosuvastatin in healthy adults

inferredcites →https://doi.org/10.2337/dc14-s014openalex-snapshot

Standards of Medical Care in Diabetes—2014

inferredcites →https://doi.org/10.2337/dc16-er09openalex-snapshot

Erratum. Classification and diagnosis of diabetes. Sec. 2. In Standards of Medical Care in Diabetes – 2016 . Diabetes Care 2016;39(Suppl. 1):S13–S22

inferredcites →https://doi.org/10.2337/diacare.29.s1.06.s4openalex-snapshot

Standards of Medical Care in Diabetes–2006

inferredcites →https://doi.org/10.32388/doq9wuopenalex-snapshot

Center for Drug Evaluation and Research

inferredcites →https://doi.org/10.3305/nh.2015.31.2.7845openalex-snapshot

Safety in the hypertriglyceridemia treatment with N-3 polyunsaturated fatty acids on glucose metabolism in subjects with type 2 diabetes mellitus.

inferredcites →https://doi.org/10.4158/ep151126.csopenalex-snapshot

Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm – 2016 EXECUTIVE SUMMARY

inferredcites →https://doi.org/10.4158/ep15672.glopenalex-snapshot

American Association of Clinical Endocrinologists and American College of Endocrinology – Clinical Practice Guidelines for Developing A Diabetes Mellitus Comprehensive Care Plan – 2015 — Executive Summary

inferredcites →https://doi.org/10.4158/ep15672.glsupplopenalex-snapshot

American Association Of Clinical Endocrinologists And American College Of Endocrinology -Clinical Practice Guidelines For Developing A Diabetes Mellitus Comprehensive Care Plan – 2015

inferredcites →https://doi.org/10.4158/ep161682.csopenalex-snapshot

Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive type 2 Diabetes Management Algorithm – 2017 Executive Summary

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4934379openalex-extracted

Associations of 26 Dietary Habits with Infection of Intervertebral Disc: A Comprehensive Two-Sample Mendelian Randomization Study

inferred← citeshttps://doi.org/10.1002/fsn3.3464openalex-snapshot

Omega‐3 fatty acid supplements and recurrent miscarriage: A perspective on potential mechanisms and clinical evidence

inferred← citeshttps://doi.org/10.1002/fsn3.784openalex-snapshot

Reduction of elevated lipids and low‐density lipoprotein oxidation in serum of individuals with subclinical hypoxia and oxidative stress supplemented with lycosome formulation of docosahexaenoic acid

inferred← citeshttps://doi.org/10.1007/s00125-020-05162-zopenalex-snapshot

Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study

inferred← citeshttps://doi.org/10.1007/s13197-023-05785-1openalex-snapshot

Development in health-promoting essential polyunsaturated fatty acids production by microalgae: a review

inferred← citeshttps://doi.org/10.1016/j.focha.2024.100695openalex-snapshot

Functional triacylglycerols from microalgae and their use in the formulation of functional foods—Review

inferred← citeshttps://doi.org/10.1016/j.foodchem.2020.128743openalex-snapshot

Enzymatic enrichment of n-3 polyunsaturated fatty acid glycerides by selective hydrolysis

inferred← citeshttps://doi.org/10.1016/j.isci.2021.102909openalex-snapshot

Vascepa protects against high-fat diet-induced glucose intolerance, insulin resistance, and impaired β-cell function

inferred← citeshttps://doi.org/10.1016/j.jafr.2025.102148openalex-snapshot

Exploring the nutraceutical and functional food potential of microalgae: Implications for health and sustainability

inferred← citeshttps://doi.org/10.1016/j.jinf.2016.10.001openalex-snapshot

Modulation of host defence against bacterial and viral infections by omega-3 polyunsaturated fatty acids

inferred← citeshttps://doi.org/10.1038/s41398-022-02217-0openalex-snapshot

Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis

inferred← citeshttps://doi.org/10.1080/07388551.2023.2196373openalex-snapshot

Thraustochytrids as a promising source of fatty acids, carotenoids, and sterols: bioactive compound biosynthesis, and modern biotechnology

inferred← citeshttps://doi.org/10.1080/10408398.2022.2086852openalex-snapshot

Progress in enrichment of n-3 polyunsaturated fatty acid: a review

inferred← citeshttps://doi.org/10.1089/jwh.2017.6757openalex-snapshot

Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis

inferred← citeshttps://doi.org/10.1136/bmj.l4009openalex-snapshot

Dietary fats and mortality among patients with type 2 diabetes: analysis in two population based cohort studies

inferred← citeshttps://doi.org/10.1186/s12937-017-0259-0openalex-snapshot

Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study

inferred← citeshttps://doi.org/10.12677/bp.2023.131009openalex-snapshot

Meningitis Pathogenic Bacteria Identification, Doublex PCR Rapid Diagnosis and Immune Protective Effect of the Vaccine in the Frog (Quasipaa spinosa)

inferred← citeshttps://doi.org/10.33667/2078-5631-2022-16-93-101openalex-snapshot

Algae and omega-3 PUFAs

inferred← citeshttps://doi.org/10.3389/fcdhc.2024.1318578openalex-snapshot

Associations of dietary linoleic acid and alpha linolenic acid intake with cardiovascular, cancer and all-cause mortalities in patients with diabetes: NHANES 1999-2008

inferred← citeshttps://doi.org/10.3390/biomass5020025openalex-snapshot

Microalgae as Functional Food Ingredients: Nutritional Benefits, Challenges, and Regulatory Considerations for Safe Consumption

inferred← citeshttps://doi.org/10.3390/md19020113openalex-snapshot

Microalgae n-3 PUFAs Production and Use in Food and Feed Industries

inferred← citeshttps://doi.org/10.7860/jcdr/2017/20628.9449openalex-snapshot

Role of Omega-3 Fatty Acids on Lipid Profile in Diabetic Dyslipidaemia: Single Blind, Randomised Clinical Trial

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.